Ultimately, to make health care more affordable, consumers paying insurance premiums must become more important than drug manufacturers
Layering on requirements for optimal pharmacological profiles and drug-like properties to support oral dosing adds another level of complexity. But acording to Terry Kenakin, a former GSK drug developer now at the University of North Carolina-Chapel Hill in the US, we are in what I call a renaissance in terms of finding compounds that modify the function of these [GPCR receptors]
Most bariatric and obesity medicine guidelines suggest sequential monotherapyoptimizing one agent before adding anotherrather than immediate combination approaches
As a result, your testicles make too little or no testosterone and sperm
Frontiers in nutrition , 12 , 1566498
doi:10.1371/journal.pone.0222135